These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Dynamism of the development of "Fc receptor-blocking antibodies" after immunization with buffy coat. Petri IB; Gyódi E; Kaiser G; Kassai M; Petrányi GG Haematologia (Budap); 1989; 22(3):135-41. PubMed ID: 2684813 [TBL] [Abstract][Full Text] [Related]
27. Prevention of HLA alloimmunization: role of leukocyte depletion and UV-B irradiation. Snyder EL Yale J Biol Med; 1990; 63(5):419-27. PubMed ID: 2293501 [TBL] [Abstract][Full Text] [Related]
28. Marginal zone B cells are responsible for the production of alloantibodies following platelet transfusion in mice. Couvidou A; Angénieux C; Ruch L; Mangin PH; Gachet C; Maître B Blood Adv; 2023 Apr; 7(8):1356-1365. PubMed ID: 36490266 [TBL] [Abstract][Full Text] [Related]
29. Vincristine therapy for severe platelet alloimmunization. Bruggers CS; Kurtzberg J; Friedman HS Am J Pediatr Hematol Oncol; 1991; 13(3):300-4. PubMed ID: 1793156 [TBL] [Abstract][Full Text] [Related]
30. Canine platelet alloimmunization: the role of donor selection. Slichter SJ; O'Donnell MR; Weiden PL; Storb R; Schroeder ML Br J Haematol; 1986 Aug; 63(4):713-27. PubMed ID: 3730294 [TBL] [Abstract][Full Text] [Related]
32. Alloimmunization after granulocyte transfusions. Stroncek DF; Leonard K; Eiber G; Malech HL; Gallin JI; Leitman SF Transfusion; 1996; 36(11-12):1009-15. PubMed ID: 8937413 [TBL] [Abstract][Full Text] [Related]
33. Sensitization by platelet transfusion. Brand A Schweiz Med Wochenschr; 1991 Mar; 121(13):467-9. PubMed ID: 2031162 [TBL] [Abstract][Full Text] [Related]
34. Stability of antigens on leukocytes in banked platelet concentrates: decline in HLA-DR antigen expression and mixed lymphocyte culture stimulating capacity following storage. Sherman ME; Dzik WH Blood; 1988 Sep; 72(3):867-72. PubMed ID: 2970874 [TBL] [Abstract][Full Text] [Related]
35. [Platelet transfusion refractoriness and effective management of platelet alloimmunization]. Amemiya Y Nihon Rinsho; 1997 Sep; 55(9):2392-8. PubMed ID: 9301306 [TBL] [Abstract][Full Text] [Related]
36. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. Trial to Reduce Alloimmunization to Platelets Study Group N Engl J Med; 1997 Dec; 337(26):1861-9. PubMed ID: 9417523 [TBL] [Abstract][Full Text] [Related]
37. FcR blocking activity in serum of actively enhanced rat renal allograft recipients due to IgG anti-class II MHC alloantibody. Marshall HE; Bolton EM; Gracie JA; Cocker JE; Sandilands GP; Bradley JA Immunology; 1990 Mar; 69(3):379-84. PubMed ID: 2312162 [TBL] [Abstract][Full Text] [Related]
38. Relationship of HLA and platelet-reactive antibodies in alloimmunized patients refractory to platelet therapy. Brubaker DB; Romine M Am J Hematol; 1987 Dec; 26(4):341-52. PubMed ID: 3687931 [TBL] [Abstract][Full Text] [Related]
39. Biologic effects of leukocytes present in transfused cellular blood products. Bordin JO; Heddle NM; Blajchman MA Blood; 1994 Sep; 84(6):1703-21. PubMed ID: 8080981 [TBL] [Abstract][Full Text] [Related]
40. Effects of leukocyte depletion and UVB irradiation on alloantigenicity of major histocompatibility complex antigens in platelet concentrates: a comparative study. Kao KJ Blood; 1992 Dec; 80(11):2931-7. PubMed ID: 1450418 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]